BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2003
View Archived Issues
Antitumor effects of ZD-6126 due to changes in endothelial cell morphology
Read More
Euglucon and Lanirapid rights to be transferred to Chugai
Read More
Cardiovascular benefits found for transdermal vs. oral estrogen in postmenopausal women
Read More
Bacterial resistance and oropharyngeal colonization after long-term antibiotic therapy for acne
Read More
Effective use of subantimicrobial doses of doxycycline in moderate facial acne
Read More
Topical testosterone improves erectile response in male hypogonadism unresponsive to sildenafil
Read More
Safety and efficacy of lofexidine in children with ADHD and tics
Read More
New NOS inhibitors and their use in arthritis, pain and migraine reported by AstraZeneca
Read More
Kaken presents new VLA-4/LPAM-1 antagonists
Read More
Thiazolidine DPP-IV inhibitors described by Mitsubishi Pharma
Read More
Novel beta-secretase inhibitors in early development at Elan
Read More
Novel adenosine A2A receptor antagonists and their use in Parkinson's disease
Read More
Suntory patent covers preparation and use of novel NF-kB activation inhibitors
Read More
Kowa researchers prepare and test orally available IL-1beta production inhibitors
Read More
Amylin fragments reported to stimulate bone growth
Read More
New FTase inhibitors in Wyeth development pipeline
Read More
Antisoma's anticancer drug AS-1406 shows promise in preclinical trials
Read More
FDA approves first treatment for Fabry's disease
Read More
ISV-403 moves into phase I clinical trials
Read More
Locus and Speedel collaborate to design novel renin inhibitors
Read More
Enrollment completed in phase IIa Onyvax-P trial
Read More
Allergan and Acadia announce new drug discovery and development collaboration
Read More
FDA approves Aldurazyme for MPS I
Read More
Full inverse agonist at an HCMV-encoded G-protein-coupled receptor identified
Read More
Approval and/or launch of major ophthalmic products reported by Allergan
Read More
Phase II trials of human GLP-1 analogue completed at Novo Nordisk
Read More
Neurocrine Biosciences acquires compound for ED divested by Pharmacia
Read More